Caribou Biosciences Inc.

1.08
-0.09 (-7.69%)
At close: Mar 03, 2025, 3:59 PM
1.09
0.93%
After-hours: Mar 03, 2025, 06:22 PM EST

Caribou Biosciences Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 51.16M 58.34M 240.42M 15.95M 41.07M
Short-Term Investments 277.67M 189.32M 135.41M n/a 8.4M
Long-Term Investments 51.33M 77.07M 45.3M 7.63M n/a
Other Long-Term Assets 1.59M 1.54M 975K 612K 593K
Receivables 3.86M 4.66M 8.12M 5.16M 3.98M
Inventory n/a -62.57M -31.11M 2.43M 3.18M
Other Current Assets 6.16M 7.92M 7.24M 3.19M 3.56M
Total Current Assets 338.84M 260.25M 391.19M 24.31M 57.01M
Property-Plant & Equipment 40.45M 34.91M 4.89M 3.5M 4.33M
Goodwill & Intangibles n/a -10.5M -2.85M -2.48M n/a
Total Long-Term Assets 93.37M 113.52M 51.16M 11.74M 4.92M
Total Assets 432.21M 373.76M 442.36M 36.05M 61.93M
Account Payables 3.12M 1.15M 3.99M 2.6M 2.54M
Deferred Revenue 2.85M 9.94M 8.7M 161K 717K
Short-Term Debt 1.2M 1.93M n/a 654K 532K
Other Current Liabilities 21.14M 15.11M 13.14M 8.97M 6.28M
Total Current Liabilities 28.3M 28.13M 25.83M 12.39M 10.08M
Long-Term Debt 25.91M 26.78M n/a 924K n/a
Other Long-Term Liabilities 2.94M 1.65M 6.19M 45.08M 42.76M
Total Long-Term Liabilities 35.51M 44.77M 28.7M 47.09M 44.39M
Total Liabilities 63.81M 72.89M 54.53M 59.48M 54.47M
Total Debt 27.11M 27.75M 259K 1.58M 532K
Common Stock 8K 6K 6K 1K 1K
Retained Earnings -299.29M -197.22M -97.79M -30.87M 3.44M
Comprehensive Income 30K -1.52M -135K -0.00 -0.00
Shareholders Equity 368.4M 300.87M 387.82M -23.44M 7.46M
Total Investments 329M 197.02K 180.71M 7.63M 8.4M